Next-generation Sequencing Service Market: Size, Share, Growth, Analysis, Key Players, Revenue, | Valuates Reports

Next-generation Sequencing Service Market Size
The Global Next Generation Sequencing (NGS) Service Market was valued at US$ 5471 million in 2023 and is anticipated to reach US$ 11758 million by 2030, witnessing a CAGR of 13.6% during the forecast period 2024-2030.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-20K14135/Global_Next_generation_Sequencing_Service_Market_Research_Report_2023

North American market for Next Generation Sequencing (NGS) Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Next Generation Sequencing (NGS) Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Next Generation Sequencing (NGS) Service in Whole-genome Sequencing is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Next Generation Sequencing (NGS) Service include 454 Life Sciences Corporation (Roche), Agilent Technologies, Biomatters, Ltd, CLC Bio, GATC biotech AG, Macrogen, BGI (Beijing Genomics Institute), Illumina and Life Technology Corporation, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Next Generation Sequencing (NGS) Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Sequencing (NGS) Service.

Report Scope
The Next Generation Sequencing (NGS) Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next Generation Sequencing (NGS) Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Next Generation Sequencing (NGS) Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-20K14135/Global_Next_generation_Sequencing_Service_Market_Research_Report_2023

Segment by Type

• Targeted Sequencing & Resequencing
• Whole Genome Sequencing
• Whole Exome Sequencing

Segment by Application
• Whole-genome Sequencing
• Exome Sequencing
• Targeted Resequencing
• De Novo Sequencing
• RNA Sequencing
• ChIP Sequencing
• Methyl Sequencing
• Others

By Company
454 Life Sciences Corporation (Roche), Agilent Technologies, Biomatters, Ltd, CLC Bio, GATC biotech AG, Macrogen, BGI (Beijing Genomics Institute), Illumina, Life Technology Corporation, EMC Corporation, Dnastar

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-20K14135/global-next-generation-sequencing-service

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.